217 related articles for article (PubMed ID: 20223370)
1. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques.
Reininger AJ; Bernlochner I; Penz SM; Ravanat C; Smethurst P; Farndale RW; Gachet C; Brandl R; Siess W
J Am Coll Cardiol; 2010 Mar; 55(11):1147-58. PubMed ID: 20223370
[TBL] [Abstract][Full Text] [Related]
2. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
[TBL] [Abstract][Full Text] [Related]
3. Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
Ebrahim M; Jamasbi J; Adler K; Megens RTA; M'Bengue Y; Blanchet X; Uhland K; Ungerer M; Brandl R; Weber C; Elia N; Lorenz R; Münch G; Siess W
Thromb Haemost; 2018 Feb; 118(2):351-361. PubMed ID: 29378359
[TBL] [Abstract][Full Text] [Related]
4. Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.
Jamasbi J; Megens RT; Bianchini M; Münch G; Ungerer M; Faussner A; Sherman S; Walker A; Goyal P; Jung S; Brandl R; Weber C; Lorenz R; Farndale R; Elia N; Siess W
J Am Coll Cardiol; 2015 Jun; 65(22):2404-15. PubMed ID: 26046734
[TBL] [Abstract][Full Text] [Related]
5. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor and atherothrombosis.
Saha D; S S; Sergeeva EG; Ionova ZI; Gorbach AV
Curr Pharm Des; 2015; 21(9):1152-7. PubMed ID: 25312727
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
[TBL] [Abstract][Full Text] [Related]
8. Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model.
Kuijpers MJ; Gilio K; Reitsma S; Nergiz-Unal R; Prinzen L; Heeneman S; Lutgens E; van Zandvoort MA; Nieswandt B; Egbrink MG; Heemskerk JW
J Thromb Haemost; 2009 Jan; 7(1):152-61. PubMed ID: 18983512
[TBL] [Abstract][Full Text] [Related]
9. Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation.
Jooss NJ; Smith CW; Slater A; Montague SJ; Di Y; O'Shea C; Thomas MR; Henskens YMC; Heemskerk JWM; Watson SP; Poulter NS
J Thromb Haemost; 2022 Nov; 20(11):2617-2631. PubMed ID: 35894121
[TBL] [Abstract][Full Text] [Related]
10. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
[TBL] [Abstract][Full Text] [Related]
11. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
[TBL] [Abstract][Full Text] [Related]
12. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.
Badimon JJ; Lettino M; Toschi V; Fuster V; Berrozpe M; Chesebro JH; Badimon L
Circulation; 1999 Apr; 99(14):1780-7. PubMed ID: 10199872
[TBL] [Abstract][Full Text] [Related]
13. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.
Colace TV; Muthard RW; Diamond SL
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1466-76. PubMed ID: 22516070
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
15. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
[TBL] [Abstract][Full Text] [Related]
16. Procoagulant human monocytes mediate tissue factor/factor VIIa-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood.
Barstad RM; Hamers MJ; Kierulf P; Westvik AB; Sakariassen KS
Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):11-6. PubMed ID: 7749805
[TBL] [Abstract][Full Text] [Related]
17. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein VI - novel target in antiplatelet medication.
Borst O; Gawaz M
Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
[TBL] [Abstract][Full Text] [Related]
19. The Btk inhibitor AB-95-LH34 potently inhibits atherosclerotic plaque-induced thrombus formation and platelet procoagulant activity.
Smith CW; Harbi MH; Garcia-Quintanilla L; Rookes K; Brown H; Poulter NS; Watson SP; Nicolson PLR; Thomas MR
J Thromb Haemost; 2022 Dec; 20(12):2939-2952. PubMed ID: 36239466
[TBL] [Abstract][Full Text] [Related]
20. Anti-GPVI Fab reveals distinct roles for GPVI signaling in the first platelet layer and subsequent layers during microfluidic clotting on collagen with or without tissue factor.
Zhang Y; Trigani KT; Shankar KN; Crossen J; Liu Y; Sinno T; Diamond SL
Thromb Res; 2022 Oct; 218():112-129. PubMed ID: 36037547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
